5 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow this condition Literature Review of Ocular Redness trials Research Report on Ocular Redness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness BTOS-HA, Lumify® - Ocular Redness | Phase 3 | Completed | Bausch & Lomb Incorporated | 578 | 2025-05-22 | 2026-05-28 |
| An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations FID 123320 Ophthalmic Solution, Vehicle - Ocular Redness, Eye Irritation | Phase 3 | Completed | Alcon Research | 283 | 2024-10-07 | 2026-01-22 |
| A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness Apraclonidine Hydrochloride Ophthalmic Solution, Vehicle - Ocular Redness | Phase 3 | Completed | Alcon Research | 159 | 2024-08-21 | 2025-10-23 |
| "Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness" Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify® (brimonidine tartrate ophthalmic solution 0.025%) - Ocular Redness | Phase 3 | Completed | Bausch & Lomb Incorporated | 380 | 2022-05-13 | 2024-08-26 |
| Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects Placebo, Brimonidine tartrate 0.025% - Ocular Redness | Phase 2 | Completed | Eye Therapies, LLC | 57 | 2012-08-01 | 2014-07-31 |
Alcon Research (2) · Bausch & Lomb Incorporated (2) · Eye Therapies, LLC (1)
United States (5)
Daniel Donatello (1)